Looking for growth without the hefty price tag? Consider NYSE:CRS.

Uncover the potential of CARPENTER TECHNOLOGY (NYSE:CRS), a growth stock that our stock screener found to be reasonably priced. NYSE:CRS is excelling in growth aspects, maintaining a healthy financial position, and still offers an attractive valuation. We'll examine each aspect in detail.

What does the Growth looks like for NYSE:CRS

ChartMill employs its own Growth Rating system for all stocks. This score, ranging from 0 to 10, is derived by evaluating different growth factors, such as EPS and revenue growth, taking into account both past performance and future projections. NYSE:CRS has earned a 7 for growth:

• CRS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 313.04%, which is quite impressive.
• Looking at the last year, CRS shows a quite strong growth in Revenue. The Revenue has grown by 8.21% in the last year.
• CRS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 29.40% yearly.
• Based on estimates for the next years, CRS will show a quite strong growth in Revenue. The Revenue will grow by 9.14% on average per year.
• The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
• The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

Valuation Assessment of NYSE:CRS

ChartMill provides a Valuation Rating to every stock, ranging from 0 to 10. This rating assesses various valuation aspects, comparing price to earnings and cash flows, while considering factors like profitability and growth. NYSE:CRS boasts a 5 out of 10:

• Based on the Price/Free Cash Flow ratio, CRS is valued a bit cheaper than the industry average as 65.61% of the companies are valued more expensively.
• CRS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
• CRS has a very decent profitability rating, which may justify a higher PE ratio.
• A more expensive valuation may be justified as CRS's earnings are expected to grow with 29.40% in the coming years.

Assessing Health for NYSE:CRS

A critical element of ChartMill's stock evaluation is the Health Rating, which spans from 0 to 10. This rating considers multiple health factors, including liquidity and solvency, both in absolute terms and relative to industry peers. NYSE:CRS has received a 6 out of 10:

• CRS has an Altman-Z score of 4.62. This indicates that CRS is financially healthy and has little risk of bankruptcy at the moment.
• CRS has a Altman-Z score of 4.62. This is in the better half of the industry: CRS outperforms 71.97% of its industry peers.
• The Debt to FCF ratio of CRS is 3.89, which is a good value as it means it would take CRS, 3.89 years of fcf income to pay off all of its debts.
• The Debt to FCF ratio of CRS (3.89) is better than 69.43% of its industry peers.
• A Debt/Equity ratio of 0.43 indicates that CRS is not too dependend on debt financing.
• A Current Ratio of 3.41 indicates that CRS has no problem at all paying its short term obligations.
• Looking at the Current ratio, with a value of 3.41, CRS is in the better half of the industry, outperforming 65.61% of the companies in the same industry.

Exploring NYSE:CRS's Profitability

ChartMill utilizes a Profitability Rating to assess stocks, scoring them on a scale of 0 to 10. This rating takes into account a variety of profitability ratios and margins, both in absolute terms and in comparison to industry peers. NYSE:CRS has earned a 6 out of 10:

• With a decent Return On Assets value of 5.66%, CRS is doing good in the industry, outperforming 78.98% of the companies in the same industry.
• CRS has a better Return On Equity (11.43%) than 80.89% of its industry peers.
• The Return On Invested Capital of CRS (10.39%) is better than 84.71% of its industry peers.
• CRS's Profit Margin of 6.75% is fine compared to the rest of the industry. CRS outperforms 72.61% of its industry peers.
• CRS has a better Operating Margin (12.83%) than 69.43% of its industry peers.
• CRS's Operating Margin has improved in the last couple of years.
• In the last couple of years the Gross Margin of CRS has grown nicely.

More Affordable Growth stocks can be found in our Affordable Growth screener.

Check the latest full fundamental report of CRS for a complete fundamental analysis.

Disclaimer

This article should in no way be interpreted as advice. The article is based on the observed metrics at the time of writing, but you should always make your own analysis and trade or invest at your own responsibility.